Biomarkers in risk stratification of acute coronary syndromes: new insights into hematologic parameters
- PMID: 19998804
Biomarkers in risk stratification of acute coronary syndromes: new insights into hematologic parameters
Comment on
-
Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes.Rev Port Cardiol. 2009 Sep;28(9):905-24. Rev Port Cardiol. 2009. PMID: 19998803 English, Portuguese.
Similar articles
-
Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management.Expert Rev Cardiovasc Ther. 2008 Apr;6(4):435-7. doi: 10.1586/14779072.6.4.435. Expert Rev Cardiovasc Ther. 2008. PMID: 18402533 No abstract available.
-
Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry.Arch Intern Med. 2009 Feb 23;169(4):372-8. doi: 10.1001/archinternmed.2008.563. Arch Intern Med. 2009. PMID: 19237721
-
A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.J Intern Med. 2007 Dec;262(6):651-8. doi: 10.1111/j.1365-2796.2007.01871.x. Epub 2007 Nov 7. J Intern Med. 2007. PMID: 17986200
-
Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes.Am Heart J. 2008 May;155(5):806-16. doi: 10.1016/j.ahj.2007.11.037. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18440326 Review.
-
Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.Minerva Cardioangiol. 2007 Aug;55(4):491-6. Minerva Cardioangiol. 2007. PMID: 17653025 Review.